Bipolar Disorder News

• Hepatitis C Meds Linked to Improved PTSD Symptoms The combination of the antiviral medications glecaprevir and pibrentasvir may improve posttraumatic stress disorder symptoms in patients with comorbid hepatitis C, new research suggests.
  Medscape Medical News, September 02, 2022
• Borderline Personality Disorder Raises MDD Relapse Risk After ECT Borderline personality disorder is significantly associated with relapse in adults with comorbid major depressive disorder who undergo electroconvulsive therapy.
  MDedge News, September 02, 2022
• Inhaled, Systemic Steroids Linked to Changes in Brain Structure New research adds to the growing body of evidence suggesting that glucocorticoids have significant effects on the brain, which could explain their neuropsychiatric side effects, experts say.
  Medscape Medical News, August 30, 2022
• Brief Psychiatric Rating Scale Succeeds as Transdiagnostic Measure The brief scale is effective for measuring general and specific psychiatric symptoms across the diagnostic spectrum, new research suggests, and may offer an alternative to DSM and ICD diagnoses.
  Medscape Medical News, August 23, 2022
• How to Spot Older Patients With Hidden Mental Health Issues Doctors can use questionnaires for older patients to detect underlying mental health issues that are mistaken for treatment adherence problems.
  Medscape Medical News, August 19, 2022
• Mixed Results for Intensive Home Care for Psychiatric Crises Intensive home treatment during a psychiatric crisis led to fewer inpatient days in the following year -- but no sustained symptom improvement, new research shows.
  Medscape Medical News, July 26, 2022
• Mistrust Lingers in Black Communities Amid 988 Launch Stories reverberate through generations, stoking mistrust of the mental health system, especially within Black communities.
  Associated Press, July 21, 2022
• Does Schizophrenia Need a Name Change? Many patients and caregivers feel that the name is woefully out of date and clinically inaccurate.
  Medscape Medical News, July 13, 2022
• Gun Safety 'Wrapped in a Mental Health Bill': Health Provisions The bulk of funds provided in the gun reform law known as the Bipartisan Safer Communities Act are for expanding mental health services. Will it help improve mental health outcomes and stem violence?
  Kaiser Health News, July 07, 2022
• Telemental Health Linked to Greater Post-Hospitalization Follow-up Patients with serious mental illness have more telehealth and/or in-person visits and more follow-ups after hospitalization in nonmetropolitan counties reporting high use of telehealth services.
  Medscape Medical News, July 06, 2022
• Officials: Nurse Practitioner Pocketed a Million in Loan Scheme New York nurse practitioner arrested for multi-year scheme defrauding a student loan fund of $10.5 million.
  Medscape Medical News, June 21, 2022
• EPA 2022 Advance Directives for Psych Care Reduce Compulsory Admissions Providing peer or community health worker support to help psychiatric patients complete advance directives is associated with a 42% reduction in compulsory hospital admissions, new research shows.
  Medscape Medical News, June 21, 2022
• SLEEP 2022 Analysis Shows Predictive Capabilities of Sleep EEG Overnight sleep electroencephalography contains brain wave data that could be mined to identify an individual's risk for a host of health outcomes, including dementia, new research suggests.
  Medscape Medical News, June 13, 2022
• Youth With Bipolar Disorder at High Risk of Eating Disorders Studies in adults point to strong comorbidity between bipolar disorder and eating disorder. This study demonstrates the same pattern in youth as well.
  June 06, 2022
• Antipsychotic Tied to Weight Gain, Higher Cholesterol The antipsychotic risperidone is associated with small dose-related increases in weight and blood cholesterol levels over time, a large new study suggests.
  Medscape Medical News, June 02, 2022
• Early Metformin Minimizes Antipsychotic-Induced Weight Gain A new guideline provides a protocol for the use of metformin, an inexpensive drug that has the most evidence for efficacy against antipsychotic-induced weight gain.
  Medscape Medical News, June 01, 2022
• When Does an Elite Athlete Need Mental Health Treatment? Nearly all athletes experience anxiety before a competition. But persistent symptoms, such as difficulty falling asleep, may indicate a need for psychotherapy or medication.
  Medscape Medical News, May 27, 2022
• APA 2022 Faster Response to IV vs Intranasal Ketamine in Depression In one of the first studies to compare efficacy of IV and intranasal ketamine, results suggest a faster response for the IV form -- although, at the end, overall response was similar.
  Medscape Medical News, May 26, 2022
• APA 2022 Antipsychotic Safe, Effective for Resistant Depression The atypical antipsychotic cariprazine, which is approved for schizophrenia and bipolar disorder, is also effective as an adjunct treatment for resistant depression, results of a new phase 3 trial show.
  Medscape Medical News, May 26, 2022
• APA 2022 Lithium May Lower Osteoporosis Risk in Bipolar Disorder Although increased risk for osteoporosis is common in bipolar disorder, lithium may provide a significant protective effect against the bone disease, results from the largest study of its kind show.
  Medscape Medical News, May 25, 2022